Jingoro Shimada
- Epidemiology top 5%
- Pharmacology top 2%
- Molecular Biology
- Molecular Medicine top 2%
- Infectious Diseases top 10%
- Co-authors
- Shigeru KohnoHiroshi KidaMasashi MizuguchiYutaka SaishoYoshihiro InouéHajime HamashimaToshiko HadaAkiko Shiraishi
- Topics
- Antibiotics Pharmacokinetics and Efficacy (25 papers)Pneumonia and Respiratory Infections (13 papers)Antibiotic Resistance in Bacteria (12 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Jingoro Shimada
69 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Epidemiology 533
- Pharmacology 357
- Molecular Biology 257
- Molecular Medicine 257
- Infectious Diseases 196
Countries citing papers authored by Jingoro Shimada
This map shows the geographic impact of Jingoro Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingoro Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingoro Shimada more than expected).
Fields of papers citing papers by Jingoro Shimada
This network shows the impact of papers produced by Jingoro Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingoro Shimada. The network helps show where Jingoro Shimada may publish in the future.
Co-authorship network of co-authors of Jingoro Shimada
This figure shows the co-authorship network connecting the top 25 collaborators of Jingoro Shimada. A scholar is included among the top collaborators of Jingoro Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingoro Shimada. Jingoro Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 92 | |
| 2 | 13 | |
| 3 | A study of doripenem efficacy and safety in internal medicine | 1 |
| 4 | A dose-finding study on doripenem in chronic respiratory tract infection | 1 |
| 5 | Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection | 3 |
| 6 | Comparative study of doripenem and meropenem in respiratory infections. Phase III double-blind comparative study | 3 |
| 7 | The Antibacterial Effects of Myrcene on Staphylococcus aureus and Its Role in the Essential Oil of the Tea Tree (Melaleuca alternifolia) | 21 |
| 8 | Inhibitory effects of terpenes on the growth of Staphylococcus aureus | 24 |
| 9 | 9 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | Clinical studies of loracarbef | 3 |
| 15 | 1 | |
| 16 | Effect of antacid on gastrointestinal absorption of fleroxacin in healthy humans | 2 |
| 17 | Effect of T-3262 and its structural derivatives on GABA receptor binding | 5 |
| 18 | 4 | |
| 19 | Clinical studies on ceftriaxone (Ro 13-9904) | 2 |
| 20 | CLINICAL STUDIES OF CEFOTAXIME | 2 |
About Jingoro Shimada
Jingoro Shimada is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases, having authored 71 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Pneumonia and Respiratory Infections (13 papers) and Antibiotic Resistance in Bacteria (12 papers). The work is most often cited by research in Molecular Medicine (257 citations), Applied Microbiology and Biotechnology (72 citations) and Pharmacology (357 citations). Jingoro Shimada has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Shigeru Kohno, Hiroshi Kida, Masashi Mizuguchi, Yutaka Saisho, Yoshihiro Inoué, Hajime Hamashima, Toshiko Hada, Akiko Shiraishi, Takayuki Katsube and Nobuo Hirotsu. Their work appears in journals such as Nucleic Acids Research, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.